Next Generation
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials
Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis…
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG Vaccine…
MTBVAC in new-borns Phase 2a trial completed its enrolment
MTBVAC in new-borns Phase 2a trial completed its enrolment…
Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal
Zendal is committed to the creation of a biotechnological pole Galicia-North of Portugal…
